From Pills to Pathways: Geriatric Pharmacology Through the Lens of Proteomics and Systems Pharmacology

Older people are major users of medicines. In addition to highly prevalent use of multiple medications (polypharmacy), ageing is accompanied by multisystem physiological decline over time with major implications in pharmacodynamics and pharmacokinetics. Accumulating clinical evidence demonstrates that certain commonly prescribed drugs and polypharmacy are associated with adverse geriatric outcomes, such as falls, frailty and […]